From: Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
 | Quartile | MetS/Total, n (%) | model 1 | model 2 | model 3 | model 4 |
---|---|---|---|---|---|---|
TSH | 1 | 578/2923 (19.8) | 1 | 1 | 1 | 1 |
2 | 595/2975 (20.0) | 1.014 (0.893–1.153) | 1.015 (0.892–1.155) | 1.030 (0.904–1.174) | 1.000 (0.861–1.161) | |
3 | 618 (2946 (21.0) | 1.077 (0.948–1.223) | 1.072 (0.943–1.219) | 1.116 (0.980–1.271) | 1.101 (0.949–1.276) | |
4 | 650/2975 (21.8) | 1.134 (1.000–1.286) | 1.110 (0.977–1.261) | 1.155 (1.015–1.314) | 1.214 (1.047–1.407) | |
FT4 | 1 | 796/2877 (27.7) | 1 | 1 | 1 | 1 |
2 | 635/3000 (21.2) | 0.702 (0.623–0.791) # | 0.717 (0.635–0.809) # | 0.704 (0.623–0.796) # | 0.816 (0.709–0.939) # | |
3 | 532/3014 (17.7) | 0.560 (0.495–0.635) # | 0.596 (0.525–0.675) # | 0.579 (0.509–0.657) # | 0.733 (0.634–0.848) # | |
4 | 478/2928 (16.3) | 0.510 (0.449–0.579) # | 0.567 (0.498–0.646) # | 0.545 (0.478–0.622) # | 0.722 (0.621–0.839) # | |
FT3 | 1 | 516/2655 (19.4) | 1 | 1 | 1 | 1 |
2 | 652/3300 (19.8) | 1.021 (0.897–1.161) | 1.192 (1.045–1.360) | 1.172 (1.026–1.339) # | 1.174 (1.010–1.366) | |
3 | 695/3185 (21.8) | 1.157 (1.018–1.315) | 1.487 (1.302–1.699) # | 1.458 (1.275–1.668) # | 1.360 (1.167–1.586) # | |
4 | 578/2679 (21.6) | 1.140 (0.998–1.303) | 1.652 (1.434–1.904) # | 1.577 (1.366–1.821) # | 1.491 (1.266–1.756) # | |
FT3FT4 | 1 | 457/2945 (15.5) | 1 | 1 | 1 | 1 |
2 | 528/2958 (17.8) | 1.183 (1.031–1.357) | 1.241 (1.080–1.426) | 1.220 (1.060–1.405) # | 1.234 (1.054–1.445) | |
3 | 667/2960 (22.5) | 1.584 (1.388–1.807) # | 1.753 (1.533–2.005) # | 1.731 (1.512–1.983) # | 1.537 (1.318–1.791) # | |
4 | 789/2956 (26.7) | 1.982 (1.743–2.255) # | 2.263 (1.984–2.582) # | 2.267 (1.984–2.590) # | 1.674 (1.438–1.948) # |